| Cat. No. |
Size |
Price |
Figures |
|---|
RP10427-5 mg
| 5 mg | $ 95.00 | HPLC: 20090217224643 (PDF)
MS: 20090217224802 (PDF)
MSDS: 20080714220803 (PDF)
STRUCTURE:
Zoom
References:
- Xia WJ, et al. Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage. Pediatr Res. Oct 2005; 58(4): 784-790.
- Ott D, et al. Engineering and functional immobilization of opioid receptors. Protein Eng. Des. Sel. Mar 2005; 18(3): 153-160.
- Mollereau C, et al. Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells. Mol. Pharmacol. Mar 2005; 67(3): 965-975.
|
|---|
| Full Name | |
Sequence
(one-letter code) |
YAFGYPS-NH2 |
Sequence
(three-letter code) | {TYR}{d-ALA}{PHE}{GLY}{TYR}{PRO}{SER}-NH2 |
|---|
| C-Terminal | NH2 |
|---|
| Description | Dermorphin has no common structure with mammalian opioid peptides. This peptide, isolated from the skin of the South American frog Phyllomedusa sauvagei, is the most selective of all m-opioid agonists. |
|---|
| Solubility | The peptide is soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents. |
|---|
| Formula | C40H50N8O10 |
|---|
| M.W. | 802.9 |
|---|
| Purity | > 95% |
|---|
| Storage | Storage at -20°C. Keep tightly closed. |
